Literature DB >> 28229304

Early elevated levels of soluble triggering receptor expressed on myeloid cells-1 in subarachnoid hemorrhage patients.

Xin-Gang Sun1, Qian Ma1, Gang Jing2, Li Wang1, Xu-Dong Hao3, Gai-Qing Wang4.   

Abstract

Early brain injury (EBI) contributes to poor prognosis of subarachnoid hemorrhage (SAH). This study aimed to clarify whether triggering receptor expressed on myeloid cells-1 (TREM-1) was implicated in the inflammatory mechanisms of EBI. The cerebrospinal fluid (CSF) levels of soluble TREM-1 (sTREM-1), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) as well as plasma levels of white blood cells (WBC) count and C-reactive protein in 17 SAH patients at early stage (within the EBI period) and 9 volunteers were observed. Also World Federation of Neurosurgical Societies (WFNS) scale of SAH patients was calculated on admission. Compared to controls, increased CSF levels of sTREM-1 (t = 5.66, P < 0.001), TNF-α (t = 5.41, P < 0.001) and IL-6 (t = 2.98, P = 0.007) as well as elevated plasma WBC counts (t = 7.61, P < 0.001) and C-reactive protein levels (t = 3.91, P = 0.001) were found in SAH patients. Considering the increased WBC counts in SAH group, covariate analysis was also performed when comparing patients' sTREM-1 levels with respect to controls and no obvious difference was found (F = 0.982, P = 0.332). For SAH group, early CSF concentrations of sTREM-1 were correlated with those of both TNF-α (r = 0.582, P = 0.014) and IL-6 (r = 0.593, P = 0.012). Also the CSF sTREM-1 levels were positively correlated with WBC counts (r = 0.629, P = 0.007) and C-reactive protein levels (r = 0.804, P < 0.001) as well as WFNS scale (r = 0.835, P < 0.001). This study showed an early increased sTREM-1 CSF level in SAH patients, which correlated with inflammation intensity post-SAH and clinical severity, indicating that TREM-1 may participate in the inflammatory mechanisms of EBI.

Entities:  

Keywords:  IL-6; Inflammation; Subarachnoid hemorrhage; TNF-α; sTREM-1

Mesh:

Substances:

Year:  2017        PMID: 28229304     DOI: 10.1007/s10072-017-2853-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  26 in total

1.  Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease.

Authors:  Michalis Tzivras; Vassilios Koussoulas; Evangelos J Giamarellos-Bourboulis; Dimitrios Tzivras; Thomas Tsaganos; Pantelis Koutoukas; Helen Giamarellou; Athanasios Archimandritis
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

2.  Association of platelet and leukocyte counts with delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage.

Authors:  K M Kasius; C J M Frijns; A Algra; G J E Rinkel
Journal:  Cerebrovasc Dis       Date:  2010-04-08       Impact factor: 2.762

Review 3.  Targeting neutrophils in ischemic stroke: translational insights from experimental studies.

Authors:  Glen C Jickling; DaZhi Liu; Bradley P Ander; Boryana Stamova; Xinhua Zhan; Frank R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-25       Impact factor: 6.200

Review 4.  Inflammatory mediators and modulation of blood-brain barrier permeability.

Authors:  N J Abbott
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

5.  Neuroprotective effects of anti-tumor necrosis factor-alpha antibody on apoptosis following subarachnoid hemorrhage in a rat model.

Authors:  Yong Jiang; Dian-Wei Liu; Xiang-Yang Han; Ya-Nan Dong; Jun Gao; Bin Du; Lei Meng; Jian-Guo Shi
Journal:  J Clin Neurosci       Date:  2012-04-18       Impact factor: 1.961

6.  TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines.

Authors:  Jun Kuai; Bernard Gregory; Andrew Hill; Debra D Pittman; Jeffrey L Feldman; Tom Brown; Brenda Carito; Margot O'Toole; Renee Ramsey; Oskar Adolfsson; Kathleen M Shields; Ken Dower; J Perry Hall; Yahya Kurdi; Jonathan T Beech; Jagdeep Nanchahal; Marc Feldmann; Brian M Foxwell; Fionula M Brennan; David G Winkler; Lih-Ling Lin
Journal:  Rheumatology (Oxford)       Date:  2009-08-27       Impact factor: 7.580

7.  Inhibitory effects of p38 inhibitor against mitochondrial dysfunction in the early brain injury after subarachnoid hemorrhage in mice.

Authors:  Liyong Huang; Jia Wan; Ying Chen; Zhongwei Wang; Lei Hui; Yan Li; Dawei Xu; Wenke Zhou
Journal:  Brain Res       Date:  2013-04-17       Impact factor: 3.252

8.  Can soluble triggering receptor expressed on myeloid cells (sTREM-1) be considered an anti-inflammatory mediator in the pathogenesis of peptic ulcer disease?

Authors:  Vassilios Koussoulas; Michalis Tzivras; Evangelos J Giamarellos-Bourboulis; Maria Demonakou; Spyridon Vassilliou; Aimilia Pelekanou; Antonios Papadopoulos; Helen Giamarellou; Charalambos Barbatzas
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

Review 9.  Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases.

Authors:  Christopher J Pelham; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2013-12-10       Impact factor: 4.473

Review 10.  Leukocyte infiltration in experimental stroke.

Authors:  Nina Vindegaard Grønberg; Flemming Fryd Johansen; Uffe Kristiansen; Henrik Hasseldam
Journal:  J Neuroinflammation       Date:  2013-09-18       Impact factor: 8.322

View more
  4 in total

Review 1.  The role of triggering receptor expressed on myeloid cells-1 (TREM-1) in central nervous system diseases.

Authors:  Chunyan Zhang; Xugang Kan; Baole Zhang; Haibo Ni; Jianfeng Shao
Journal:  Mol Brain       Date:  2022-10-22       Impact factor: 4.399

2.  D-dimer may predict poor outcomes in patients with aneurysmal subarachnoid hemorrhage: a retrospective study.

Authors:  Jun-Hui Liu; Xiang-Kui Li; Zhi-Biao Chen; Qiang Cai; Long Wang; Ying-Hu Ye; Qian-Xue Chen
Journal:  Neural Regen Res       Date:  2017-12       Impact factor: 5.135

3.  sTREM-1 promotes the phagocytic function of microglia to induce hippocampus damage via the PI3K-AKT signaling pathway.

Authors:  Li Lu; Xuan Liu; Juanhua Fu; Jun Liang; Yayi Hou; Huan Dou
Journal:  Sci Rep       Date:  2022-04-29       Impact factor: 4.996

4.  The associations between plasma soluble Trem1 and neurological diseases: a Mendelian randomization study.

Authors:  Xiaolei Shi; Tao Wei; Yachun Hu; Meng Wang; Yi Tang
Journal:  J Neuroinflammation       Date:  2022-09-06       Impact factor: 9.587

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.